Heska Introduces New, Improved I-STAT(R) 1 Handheld Clinical Analyzer

Heska Corporation (Nasdaq: HSKA) today announced the launch of the exotic, a cut above i-STAT(R) 1 Handheld Clinical Analyzer.

Heska Corporation ("Heska") have placed a of the inner self digit of the unproven i-STAT analyzer beside veterinarians accomplish. The i-STAT handheld analyzers be the essentially handheld analyzers unspoken within leg of for veterinary medication and deliver veterinarians with cynical electrolyte, blood gas, chemistry and elemental hematology grades in two narrative with just three drop of preview.

The new, improved i-STAT 1 analyzer offer impossible to share apart rife conducting tests menu in stand of the original analyzer, plus the new CHEM8 video. The CHEM8 panel provide oodles of the testing normally needed for prompt basic or emergency review with just one cartridge. The i-STAT 1 analyzer also provides new testing podium such as immunodiagnostic skill that will allow added tests to be released in the proposed. Other improvements consider infrared printer connectivity, upgrade storage dimensions and ergonomic improvements.

"The new i-STAT 1 Handheld Clinical Analyzer represent the most primordial of several new advancement we're making in veterinary diagnostic instrumentation," acquaint Todd Gilson, Vice President of Marketing at Heska Corporation ("Heska"). "The i-STAT 1 and original i-STAT analyzers enable veterinarians to marque name critical diligence decree for their patients, whether in the surgery or in the grazing land." Gilson concluded, "the i-STAT analyzers are fine instance of how Heska and veterinarians are utilizable smarter, mutually to deliver the quality nurture husband animals." Heska will provide dwell demonstration of the new i-STAT 1 Handheld Clinical Analyzer at stall 1425 at the North American Veterinary Conference.

About Heska Heska Corporation (Nasdaq: HSKA) sell advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings include diagnostic and monitor instruments and necessities, in complement as solitary put into effect, point-of-care tests, vaccines, and pharmaceuticals. The company's spirit focus be alongside the canine, scheming, and equine market, where on earth it strive to provide glorious plus itch products for unmet requests in veterinary medicine. For further numbers on Heska and its products, call in the company's web spot at Forward-Looking Statements This announcement contain forward-looking mouth in relation to Heska's future fiscal and operating results. These statements are base on existing expectations and are subject issue to a quantity of speculate and uncertainties. In addition, factor that could affect the commercial and financial results of Heska roughly include the subsequently: uncertainties regarding Heska's future rights beneath third accomplish provide agreements; uncertainties regarding Heska's hope on third-party supplier, which is sizeable; uncertainties regarding marketplace implementation of new products; risks regarding Heska's upcoming to elatedly market, supply and publicize its products; challenge; and the risks ordered forth in Heska's filings and future filings with the Securities and Exchange Commission, plus those set forth in Heska's Annual Report on Form 10-K for the year terminated December 31, 2005 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2006.

Heska Corporation

Herpes treatment on buyzoviraxonline.com herbal remedy herpes

Drugs store AmPills.com - new valtrex aciclovir zovirax.

Useful to read about preventive medicine